Pim-3 protects against hepatic failure in D-galactosamine (D-GalN)-sensitized rats

European Journal of Clinical Investigation

Volumn 40, Issue 2, 2010, Pages 127-138

  Liu, L M ^a,b   Zhang, J X ^a   Wang, X P ^b   Guo, H X ^a   Deng, H ^a   Luo, J ^a  

^a NANCHANG UNIVERSITY   (China)

^b Shanghai Songjiang District Central Hospital   (China)

Author keywords

Anti apoptosis; Cytokine; Gene therapy; Hepatic failure; Pim 3

Indexed keywords

AMINOTRANSFERASE; CASPASE 3; GALACTOSAMINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIVER ENZYME; MESSENGER RNA; PIM 3; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; RINGER SOLUTION; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; HYDRODYNAMICS; IN VIVO STUDY; INFLAMMATION; LIVER; LIVER FAILURE; LIVER HISTOLOGY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SURVIVAL RATE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CYTOKINES; GALACTOSAMINE; LIPOPOLYSACCHARIDES; LIVER; LIVER FAILURE; MALE; NITRIC OXIDE SYNTHASE TYPE II; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, WISTAR; RNA, MESSENGER; TRANSAMINASES;

EID: 75149132663     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02235.x     Document Type: Article

References (41)

1. Singhal S, Jain S, Kohaar I, Singla M, Gondal R, Kar P. Apoptotic mechanisms in fulminant hepatic failure: potential therapeutic target. Appl Immunohistochem Mol Morphol 2009 17 : 282 285.
2. Mukherjee S, Mahmoudi TM, Mukherjee U. Liver transplant for viral hepatitis and fulminant hepatic failure. Minerva Gastroenterol Dietol 2009 55 : 83 100.
3. Takamura M, Matsuda Y, Yamaquwa S, Tamura Y, Honda Y, Suzuki K et al. An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins. Life Sci 2007 80 : 1335 1344.
4. Mignon A, Rouquet N, Fabre M, Martin S, Pages JC, Dhainaut JF et al. LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. Am J Respir Crit Care Med 1999 159 : 1308 1315.
5. Fukuda T, Mogami A, Tanaka H, Yoshikawa T, Hisadome M, Komatsu H. Y-40138, a multiple cytokine production modulator, protects against D-galactosamine and lipopolysaccharide-induced hepatitis. Life Sci 2006 79 : 822 827.
6. Hu XF, Li J, Vandervalk S, Wang Z, Magnuson NS, Xing PX. Pim-1-specific mAb suppresses human and mouse tumor growth by decreasing Pim-1 levels, reducing Akt phosphorylation, and activating apoptosis. J Clin Invest 2009 119 : 362 375.
7. Katakami N, Kaneto H, Hao H, Umayahara Y, Fujitani Y, Sakamoto K et al. Role of Pim-1 in smooth muscle cell proliferation. J Biol Chem 2004 279 : 54742 54749.
8. Didichenko SA, Spiegl N, Brunner T, Dahinden CA. IL-3 induces a Pim-1-dependent antiapoptotic pathway in primary human basophils. Blood 2008 112 : 3949 3958.
9. Fox CJ, Hammerman PS, Cinalli RM, Master SR, Chodosh LA, Thompson CB. The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev 2003 17 : 1841 1854.
10. Shirogane T, Fukada T, Muller JM, Shima DT, Hibi M, Hirano T. Synergistic roles for Pim-1 and c-myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity 1999 11 : 709 719.
11. Bachmann M, Hennemann H, Xing PX, Hoffmann I, Morov T. The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1). J Biol Chem 2004 279 : 48319 48328.
12. Beharry Z, Zemskova M, Mahajam S, Zhang F, Ma J, Xia Z et al. Novel benzylidene-thiazolidine-2, 4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells. Mol Cancer Ther 2009 8 : 1473 1483.
13. Zippo A, De Robertis A, Bardelli M, Galvagni F, Oliviero S. Identification of Flk-1 target genes in vasculogenesis: pim-1 is required for endothelial and mural cell differentiation in vitro. Blood 2004 103 : 4536 4544.
14. Zhang P, Wang H, Min X, Wang Y, Tang J, Cheng J et al. Pim-3 is expressed in endothelial cells and promotes vascular tube formation. J Cell Physiol 2009 220 : 82 90.
15. Borg KE, Zhang M, Hegge D, Stephen RL, Buckley DJ, Magnuson NS et al. Prolactin regulation of pim-1 expression: positive and negative promoter elements. Endocrinology 1999 140 : 5659 5668.
16. Rozga J. Hepatocyte proliferation in health and in liver failure. Med Sci Monit 2002 8 : RA32 8.
17. Fujii C, Nakamoto Y, Lu P, Tsuneyama K, Popivanova BK, Kaneko S et al. Aberrant expression of serine/threonine kinase pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines. Int J Cancer 2005 114 : 209 219.
18. Li YY, Popivanova BK, Nagai Y, Ishikura H, Fujii C, Mukaida N. Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines. Cancer Res 2006 66 : 6741 6747.
19. Popivanova BK, Li YY, Zheng H, Omura K, Fujii C, Tsuneyama K et al. Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis. Cancer Sci 2007 98 : 321 328.
20. Lu A, Tang Y, Ran R, Clark JF, Aronow BJ, Sharp FR. Genomics of the periinfarction cortex after focal cerebral ischemia. J Cereb Blood Flow Metab 2003 23 : 786 810.
21. Maruyama H, Higuchi N, Kameda S, Miyazaki J, Gejyo F. Rat liver-targeted naked plasmid DNA transfer by tail vein injection. Mol Biotechnol 2004 26 : 165 172.
22. Maruyama H, Higuchi N, Nishikawa Y, Kameda S, Iino N, Kazama JJ et al. High-level expression of naked DNA delivered to rat liver via tail vein injection. J Gene Med 2002 4 : 333 341.
23. Bahrami S, Redl H, Leichtfried G, Yu Y, Schlag G. Similar cytokine but different coagulation responses to lipopolysaccharide injection in D-galactosamine-sensitized versus nonsensitized rats. Infect Immun 1994 62 : 99 105.
24. Magness ST, Jijon H, Fisher NVH, Sharpless NE, Brenner DA, Jobin C. In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-κB activation using a novel gene-targeted enhanced GFP reporter gene mouse. J Immunol 2004 173 : 1561 1570.
25. Galanos C, Freudenburg MA, Reutter W. Galactosamine-induced sensitization to the lethal effect of endotoxin. Proc Natl Acad Sci USA 1979 76 : 5939 5943.
26. Thirunavukkarasu C, Uemura T, Wang LF, Watkins SC, Gandhi CR. Normal rat hepatic stellate cells respond to endotoxin in LBP-independent manner to produce inhibitor(s) of DNA synthesis in hepatocytes. J Cell Physiol 2005 204 : 654 665.
27. Buckley AR, Buckley DJ, Leff MA, Hoover DS, Magnuson NS. Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells. Endocrinology 1995 136 : 5252 5259.
28. Jaster R, Tschirch E, Bittorf T, Brock J. Interferon-alpha inhibits proliferation of Ba/F3 cells by interfering with interleukin-3 action. Cell Signal 1999 11 : 769 775.
29. Narimatsu M, Maeda H, Itoh S, Atsumi T, Ohtani T, Nishida K et al. Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in T cells. Mol Cell Biol 2001 21 : 6615 6625.
30. Chen XP, Losman JA, Cowan S, Donahue E, Fay S, Vuong BQ et al. Pim serine/threonine kinase regulate the stability of Socs-1 protein. Proc Natl Acad Sci USA 2002 99 : 2175 2180.
31. Liu LM, Zhang JX, Luo J, Guo HX, Deng H, Chen JY et al. A role of cell apoptosis in lipopolysaccharide (LPS)-induced nonlethal liver injury in D-galactosamine (D-GalN)-sensitized rats. Dig Dis Sci 2008 53 : 1316 1324.
32. Nowak M, Gaines GC, Rosenberg J, Minter R, Bahjat FR, Rectenwald J et al. LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF- and the TNF-p55 receptor. Am J Physiol Regul Integr Comp Physiol 2000 278 : R1202 9.
33. Sass G, Koerber K, Bang R, Guehring H, Tiegs G. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J Clin Invest 2001 107 : 439 447.
34. Morikawa A, Kato Y, Sugiyama T, Koide N, Chakravortty D, Yoshida T et al. Role of nitric oxide in lipopolysaccharide-induced hepatic injury in D-galactosamine-sensitized mice as an experimental endotoxic shock model. Infect Immun 1999 67 : 1018 1024.
35. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with NMDA or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995 92 : 7162 7166.
36. Lin K, Xue JY, Nomen M, Spur B, Wong PY. Peroxynitrite-induced apoptosis in HL-60 cells. J Biol Chem 1995 270 : 16487 16490.
37. Pratt MAC, Niu MY. Bcl-2 controls caspase activation following a p53-dependent cyclin D1-induced death signal. J Biol Chem 2003 278 : 14219 14229.
38. Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis-the p53 network. J Cell Sci 2003 116 : 4077 4085.
39. 2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death. J Biol Chem 2005 280 : 23829 23836.
40. Cory S, Adams JM. The Bcl2 family:regulators of the cellular life-or-death switch. Nat Rev Cancer 2002 2 : 647 656.
41. Kim PK, Annis MG, Dlugosz PJ, Leber B, Andrew DW. During apoptosis Bcl-2 changes membrane topology at both the endoplasmic reticulum and mitochondria. Mol Cell 2004 14 : 523 529.